Gekko Brief
AI summaryOct 12 close
This week's news flow for Global Partners is mostly unrelated to the company itself, with several items concerning GLP-1 drug developments from other firms that merely share the same ticker letters. The more relevant mentions include an industry outlook piece grouping Global Partners with Western Midstream and NGL Energy Partners, and a Stock Traders Daily analysis describing a positive near-term sentiment alongside a mid-term weak bias and long-term strength. Filing activity also surfaced, with ALPS Advisors reporting an amended Schedule 13G covering 17.78% of the class, though this is background rather than a market-moving event.
Shares closed at $49.14, down 0.5%, sitting between the 50-day moving average of $49.87 and the 200-day average of $47.58. The one-month return stands at -6.8%, while the three, six, and twelve-month returns are 0.8%, 7.2%, and 10.4% respectively. The GekkoIndex reads 56.7, placing the stock in the Neutral zone, down from a five-day change of -11.1. Price sits 19.7% above the Gekko Fair Value of $41.06.
Earnings are scheduled for 6 November 2026, 24 days out, which falls inside a typical 20-trading-day holding window; the prior quarter saw EPS of $1.86 against a $1.24 estimate, with a 3.1% reaction. Over the last 90 days, there have been 5 insider purchases totaling $1,271,750. Seasonality over 5 years shows a 3.1% average 20-day return from this point, with gains in 4 of those years. The sole covering analyst holds a Hold rating with a consensus target of $45, implying -8.4% versus the current price.